glp-1 agonist and gastroparesis New data links agonists for weight loss with higher risk for pancreatitis, GI events Gastrointestinal Motility Effects of GLP-1

Nevertheless, GLP-1RA therapy is associated with a pattern of adverse ...

GLP-1 (Glucagon-Like Peptide-1) agonists work by: Increasing insulin secretion Delaying gastric emptying Reducing appetite via central mechanisms The result

Find out more here.

Are they worthy of all the hype? History is littered with failed weight-loss wonder drugs

Purpose of Review This review summarizes the current understanding of the physiologic influence of GLP-1 RAs on gastrointestinal motility, highlights key clinical implications of these effects, and defines areas for future investigation

Semaglutide works in a similar way by helping to slow down how quickly food leaves the stomach and by acting on areas of the brain involved in appetite control